Peer Navigation for HIV Prevention (MATCH Trial)

N/A

Waitlist Available

Led By Tiara C. Willie, PhD, MA

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Never taken PrEP

Reports unprotected vaginal or anal sex in the past 6 months with a male sexual partner

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2-months post-randomization, 4-months post-randomization, and 6-months post-randomization

Summary

This trial aims to study why Black women have low access to HIV prevention methods like PrEP, especially due to challenges like intimate partner violence and racism. The researchers want to implement and evaluate a new intervention

Who is the study for?

This trial is for Black women at high risk of HIV, focusing on those who have faced intimate partner violence and gendered racism. It aims to help them start using pre-exposure prophylaxis (PrEP) for HIV prevention.

What is being tested?

The study tests a multilevel intervention that includes peer navigation support to increase the initiation of PrEP among Black women in Baltimore, both with and without experiences of domestic violence.

What are the potential side effects?

Since this trial focuses on the implementation of a peer navigation group rather than a medical treatment, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never taken PrEP medication.

Select...

I have had unprotected sex with a male partner in the last 6 months.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2-months post-randomization, 4-months post-randomization, and 6-months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2-months post-randomization, 4-months post-randomization, and 6-months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-months post-randomization, 4-months post-randomization, and 6-months post-randomization for reporting.